{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:50:05Z","timestamp":1790700605847,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Finnish Otorhinolaryngology \u2013 Head and Neck Surgery (ORL-HNS) Foundation"},{"DOI":"10.13039\/100007798","name":"Helsingin Yliopiston Tiedes\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00262-019-02362-4","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:24:11Z","timestamp":1561469051000},"page":"1263-1272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0117-8559","authenticated-orcid":false,"given":"Timo","family":"Carp\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-3052","authenticated-orcid":false,"given":"Timo","family":"Sorsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1354-8027","authenticated-orcid":false,"given":"Lauri","family":"Jouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8817-896X","authenticated-orcid":false,"given":"Taina","family":"Tervahartiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-4965","authenticated-orcid":false,"given":"Caj","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0738-5698","authenticated-orcid":false,"given":"Stina","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-1085","authenticated-orcid":false,"given":"Jussi","family":"Tarkkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-366X","authenticated-orcid":false,"given":"Hesham","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-2404","authenticated-orcid":false,"given":"Antti","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-7881","authenticated-orcid":false,"given":"Jaana","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-1811","authenticated-orcid":false,"given":"Petri S.","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"5","key":"2362_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/hed.22015","volume":"35","author":"H Mehanna","year":"2013","unstructured":"Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 35(5):747\u2013755. \n                    https:\/\/doi.org\/10.1002\/hed.22015","journal-title":"Head Neck"},{"issue":"6","key":"2362_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.canep.2013.09.011","volume":"37","author":"S Habbous","year":"2013","unstructured":"Habbous S, Chu KP, Qiu X, La Delfa A, Harland LT, Fadhel E, Hui A, Perez-Ordonez B, Weinreb I, Liu FF, Waldron J, O\u2019Sullivan B, Goldstein D, Xu W, Huang SH, Liu G (2013) The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Cancer Epidemiol 37(6):820\u2013829. \n                    https:\/\/doi.org\/10.1016\/j.canep.2013.09.011","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"2362_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/PPO.0000000000000115","volume":"21","author":"AP Stein","year":"2015","unstructured":"Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambert PF, Kimple RJ (2015) Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review. Cancer J 21(3):138\u2013146. \n                    https:\/\/doi.org\/10.1097\/PPO.0000000000000115","journal-title":"Cancer J"},{"issue":"4","key":"2362_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/0284186x.2017.1400688","volume":"57","author":"L Jouhi","year":"2018","unstructured":"Jouhi L, Halme E, Irjala H, Saarilahti K, Koivunen P, Pukkila M, Hagstrom J, Haglund C, Lindholm P, Hirvikoski P, Vaittinen S, Ellonen A, Tikanto J, Blomster H, Laranne J, Grenman R, Makitie A, Atula T (2018) Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland. Acta Oncol 57(4):541\u2013551. \n                    https:\/\/doi.org\/10.1080\/0284186x.2017.1400688","journal-title":"Acta Oncol"},{"issue":"6","key":"2362_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jnci\/djn025","volume":"100","author":"ML Gillison","year":"2008","unstructured":"Gillison ML, D\u2019Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407\u2013420. \n                    https:\/\/doi.org\/10.1093\/jnci\/djn025","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2362_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100(4):261\u2013269. \n                    https:\/\/doi.org\/10.1093\/jnci\/djn011","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2362_CR7","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ijc.22851","volume":"121","author":"CC Ragin","year":"2007","unstructured":"Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121(8):1813\u20131820. \n                    https:\/\/doi.org\/10.1002\/ijc.22851","journal-title":"Int J Cancer"},{"issue":"1","key":"2362_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24\u201335. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"issue":"3","key":"2362_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161\u2013174. \n                    https:\/\/doi.org\/10.1038\/nrc745","journal-title":"Nat Rev Cancer"},{"issue":"45","key":"2362_CR10","doi-asserted-by":"publisher","first-page":"30433","DOI":"10.1074\/jbc.R800035200","volume":"283","author":"C Lopez-Otin","year":"2008","unstructured":"Lopez-Otin C, Bond JS (2008) Proteases: multifunctional enzymes in life and disease. J Biol Chem 283(45):30433\u201330437. \n                    https:\/\/doi.org\/10.1074\/jbc.R800035200","journal-title":"J Biol Chem"},{"issue":"7","key":"2362_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/07853890.2013.823779","volume":"45","author":"M Lempinen","year":"2013","unstructured":"Lempinen M, Lyytinen I, Nordin A, Tervahartiala T, Makisalo H, Sorsa T, Isoniemi H (2013) Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma. Ann Med 45(7):482\u2013487. \n                    https:\/\/doi.org\/10.3109\/07853890.2013.823779","journal-title":"Ann Med"},{"issue":"8","key":"2362_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827\u2013839. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000070112.80711.3D","journal-title":"Circ Res"},{"issue":"24","key":"2362_CR13","doi-asserted-by":"publisher","first-page":"11545","DOI":"10.1158\/0008-5472.Can-05-2861","volume":"65","author":"A Karadag","year":"2005","unstructured":"Karadag A, Fedarko NS, Fisher LW (2005) Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res 65(24):11545\u201311552. \n                    https:\/\/doi.org\/10.1158\/0008-5472.Can-05-2861","journal-title":"Cancer Res"},{"issue":"1","key":"2362_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10555-006-7893-x","volume":"25","author":"R Chirco","year":"2006","unstructured":"Chirco R, Liu XW, Jung KK, Kim HR (2006) Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25(1):99\u2013113. \n                    https:\/\/doi.org\/10.1007\/s10555-006-7893-x","journal-title":"Cancer Metastasis Rev"},{"key":"2362_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/284067a0","volume":"284","author":"LA Liotta","year":"1980","unstructured":"Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67. \n                    https:\/\/doi.org\/10.1038\/284067a0","journal-title":"Nature"},{"issue":"1","key":"2362_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.03.015","journal-title":"Cell"},{"issue":"8","key":"2362_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/hupa.2000.9756","volume":"31","author":"Y Imanishi","year":"2000","unstructured":"Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H (2000) Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 31(8):895\u2013904. \n                    https:\/\/doi.org\/10.1053\/hupa.2000.9756","journal-title":"Hum Pathol"},{"issue":"4","key":"2362_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.oooo.2014.12.019","volume":"119","author":"A Ahmed Haji Omar","year":"2015","unstructured":"Ahmed Haji Omar A, Haglund C, Virolainen S, Hayry V, Atula T, Kontio R, Salo T, Sorsa T, Hagstrom J (2015) MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol 119(4):459\u2013467. \n                    https:\/\/doi.org\/10.1016\/j.oooo.2014.12.019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"2362_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.1078","volume":"197","author":"M Moilanen","year":"2002","unstructured":"Moilanen M, Pirila E, Grenman R, Sorsa T, Salo T (2002) Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 197(1):72\u201381. \n                    https:\/\/doi.org\/10.1002\/path.1078","journal-title":"J Pathol"},{"key":"2362_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2407-8-77","volume":"8","author":"J Decock","year":"2008","unstructured":"Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R (2008) Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. BMC Cancer 8:77. \n                    https:\/\/doi.org\/10.1186\/1471-2407-8-77","journal-title":"BMC Cancer"},{"issue":"4","key":"2362_CR21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/sj.bjc.6604239","volume":"98","author":"JT Korpi","year":"2008","unstructured":"Korpi JT, Kervinen V, M\u00e4klin H, V\u00e4\u00e4n\u00e4nen A, Lahtinen M, L\u00e4\u00e4r\u00e4 E, Ristim\u00e4ki A, Thomas G, Ylipalosaari M, \u00c5str\u00f6m P, Lopez-Otin C, Sorsa T, Kantola S, Piril\u00e4 E, Salo T (2008) Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer. Br J Cancer 98(4):766\u2013775. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6604239","journal-title":"Br J Cancer"},{"issue":"4","key":"2362_CR22","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1002\/ijc.26435","volume":"131","author":"JP Vayrynen","year":"2012","unstructured":"Vayrynen JP, Vornanen J, Tervahartiala T, Sorsa T, Bloigu R, Salo T, Tuomisto A, Makinen MJ (2012) Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int J Cancer 131(4):E463\u2013E474. \n                    https:\/\/doi.org\/10.1002\/ijc.26435","journal-title":"Int J Cancer"},{"issue":"8","key":"2362_CR23","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.can-07-5154","volume":"68","author":"A Gutierrez-Fernandez","year":"2008","unstructured":"Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL, Jones JL, Span PN, Sweep FC, Puente XS, Lopez-Otin C (2008) Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Can Res 68(8):2755\u20132763. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-07-5154","journal-title":"Can Res"},{"issue":"1","key":"2362_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0014-5793(92)80015-9","volume":"298","author":"T Hayakawa","year":"1992","unstructured":"Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells a possible new growth factor in serum. FEBS Lett 298(1):29\u201332. \n                    https:\/\/doi.org\/10.1016\/0014-5793(92)80015-9","journal-title":"FEBS Lett"},{"issue":"1","key":"2362_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajpath.2011.09.008","volume":"180","author":"CS Moore","year":"2012","unstructured":"Moore CS, Crocker SJ (2012) An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 180(1):12\u201316. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2011.09.008","journal-title":"Am J Pathol"},{"issue":"8","key":"2362_CR26","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/cncr.20965","volume":"103","author":"V Gouyer","year":"2005","unstructured":"Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Cr\u00e9me E, Wurtz A, Porte H, Huet G (2005) Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Cancer 103(8):1676\u20131684. \n                    https:\/\/doi.org\/10.1002\/cncr.20965","journal-title":"Cancer"},{"issue":"9","key":"2362_CR27","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1158\/1078-0432.CCR-04-2277","volume":"11","author":"H Ruokolainen","year":"2005","unstructured":"Ruokolainen H, P\u00e4\u00e4kk\u00f6 P, Turpeenniemi-Hujanen T (2005) Tissue inhibitor of matrix metalloproteinase-1 Is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin Cancer Res 11(9):3257","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2362_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.oraloncology.2010.03.002","volume":"46","author":"P Pradhan-Palikhe","year":"2010","unstructured":"Pradhan-Palikhe P, Vesterinen T, Tarkkanen J, Leivo I, Sorsa T, Salo T, Mattila PS (2010) Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer. Oral Oncol 46(7):514\u2013518. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2010.03.002","journal-title":"Oral Oncol"},{"issue":"1","key":"2362_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<44::AID-IJC9>3.0.CO;2-P","volume":"84","author":"K McCarthy","year":"1999","unstructured":"McCarthy K, Maguire T, McGreal G, McDermott E, O\u2019Higgins N, Duffy Michael J (1999) High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int J Cancer 84(1):44\u201348. \n                    https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19990219)84:1%3c44:AID-IJC9%3e3.0.CO;2-P","journal-title":"Int J Cancer"},{"issue":"13","key":"2362_CR30","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0959-8049(03)00427-1","volume":"39","author":"L Manenti","year":"2003","unstructured":"Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R (2003) Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer 39(13):1948\u20131956. \n                    https:\/\/doi.org\/10.1016\/S0959-8049(03)00427-1","journal-title":"Eur J Cancer"},{"issue":"17","key":"2362_CR31","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/sj.emboj.7601281","volume":"25","author":"KK Jung","year":"2006","unstructured":"Jung KK, Liu XW, Chirco R, Fridman R, Kim HR (2006) Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J 25(17):3934\u20133942. \n                    https:\/\/doi.org\/10.1038\/sj.emboj.7601281","journal-title":"EMBO J"},{"issue":"27","key":"2362_CR32","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.127re6","volume":"1","author":"WG Stetler-Stevenson","year":"2008","unstructured":"Stetler-Stevenson WG (2008) Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signaling 1(27):re6. \n                    https:\/\/doi.org\/10.1126\/scisignal.127re6","journal-title":"Sci Signaling"},{"issue":"41","key":"2362_CR33","doi-asserted-by":"publisher","first-page":"40364","DOI":"10.1074\/jbc.M302999200","volume":"278","author":"XW Liu","year":"2003","unstructured":"Liu XW, Bernardo MM, Fridman R, Kim HR (2003) Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase\/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 278(41):40364\u201340372. \n                    https:\/\/doi.org\/10.1074\/jbc.M302999200","journal-title":"J Biol Chem"},{"issue":"1","key":"2362_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-016-0427-7","volume":"35","author":"G Song","year":"2016","unstructured":"Song G, Xu S, Zhang H, Wang Y, Xiao C, Jiang T, Wu L, Zhang T, Sun X, Zhong L, Zhou C, Wang Z, Peng Z, Chen J, Wang X (2016) TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K\/AKT and MAPK pathway. J Exp Clin Cancer Res 35(1):148. \n                    https:\/\/doi.org\/10.1186\/s13046-016-0427-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"2362_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00066-018-1309-z","volume":"194","author":"T Carpen","year":"2018","unstructured":"Carpen T, Saarilahti K, Haglund C, Markkola A, Tarkkanen J, Hagstrom J, Mattila P, Makitie A (2018) Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy. Strahlenther Onkol 194(8):759\u2013770. \n                    https:\/\/doi.org\/10.1007\/s00066-018-1309-z","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"2362_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/00016489.2017.1405279","volume":"138","author":"T Carpen","year":"2018","unstructured":"Carpen T, Sjoblom A, Lundberg M, Haglund C, Markkola A, Syrjanen S, Tarkkanen J, Makitie A, Hagstrom J, Mattila P (2018) Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients. Acta Otolaryngol 138(5):513\u2013518. \n                    https:\/\/doi.org\/10.1080\/00016489.2017.1405279","journal-title":"Acta Otolaryngol"},{"key":"2362_CR37","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (2017) AJCC cancer staging manual, 8th edn. Springer, New York, p 2017","edition":"8"},{"issue":"50","key":"2362_CR38","doi-asserted-by":"publisher","first-page":"31504","DOI":"10.1074\/jbc.272.50.31504","volume":"272","author":"R Hanemaaijer","year":"1997","unstructured":"Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VWM, Helaakoski T, Kainulainen T, R\u00f6nk\u00e4 H, Tschesche H, Salo T (1997) Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells: regulation by tumor necrosis factor-\u03b1 and doxycycline. J Biol Chem 272(50):31504\u201331509","journal-title":"J Biol Chem"},{"issue":"12","key":"2362_CR39","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1161\/ATVBAHA.107.154831","volume":"27","author":"AM Tuomainen","year":"2007","unstructured":"Tuomainen AM, Nyyssonen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, Sorsa T, Pussinen PJ (2007) Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 27(12):2722\u20132728. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.107.154831","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2362_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1600-0714.2011.01110.x","volume":"41","author":"LK Makinen","year":"2012","unstructured":"Makinen LK, Hayry V, Atula T, Haglund C, Keski-Santti H, Leivo I, Makitie A, Passador-Santos F, Bockelman C, Salo T, Sorsa T, Hagstrom J (2012) Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J Oral Pathol Med 41(5):394\u2013399. \n                    https:\/\/doi.org\/10.1111\/j.1600-0714.2011.01110.x","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"2362_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.ijg.0000212229.57922.72","volume":"15","author":"M Maatta","year":"2006","unstructured":"Maatta M, Tervahartiala T, Vesti E, Airaksinen J, Sorsa T (2006) Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma. J Glaucoma 15(3):229\u2013237. \n                    https:\/\/doi.org\/10.1097\/01.ijg.0000212229.57922.72","journal-title":"J Glaucoma"},{"issue":"11","key":"2362_CR42","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/01.Lab.0000035023.53893.B6","volume":"82","author":"K Prikk","year":"2002","unstructured":"Prikk K, Maisi P, Piril\u00e4 E, Reintam M-A, Salo T, Sorsa T, Sepper R (2002) Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest 82(11):1535\u20131545. \n                    https:\/\/doi.org\/10.1097\/01.Lab.0000035023.53893.B6","journal-title":"Lab Invest"},{"key":"2362_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1749-6632.1999.tb07679.x","volume":"878","author":"T Sorsa","year":"1999","unstructured":"Sorsa T, Mantyla P, Ronka H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O, Tikanoja S (1999) Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 878:130\u2013140","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2362_CR44","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/ijc.22980","volume":"121","author":"SJ Smeets","year":"2007","unstructured":"Smeets SJ, Hesselink AT, Speel E-JM, Haesevoets A, Snijders PJF, Pawlita M, Meijer CJLM, Braakhuis BJM, Leemans CR, Brakenhoff RH (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11):2465\u20132472. \n                    https:\/\/doi.org\/10.1002\/ijc.22980","journal-title":"Int J Cancer"},{"issue":"5","key":"2362_CR45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ijc.30516","volume":"140","author":"E-S Prigge","year":"2017","unstructured":"Prigge E-S, Arbyn M, von Knebel Doeberitz M, Reuschenbach M (2017) Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 140(5):1186\u20131198. \n                    https:\/\/doi.org\/10.1002\/ijc.30516","journal-title":"Int J Cancer"},{"key":"2362_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.oraloncology.2018.06.012","volume":"83","author":"C Gronhoj","year":"2018","unstructured":"Gronhoj C, Jakobsen KK, Jensen DH, Rasmussen J, Andersen E, Friborg J, von Buchwald C (2018) Pattern of and survival following loco-regional and distant recurrence in patients with HPV\u2009+\u2009and HPV- oropharyngeal squamous cell carcinoma: a population-based study. Oral Oncol 83:127\u2013133. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2018.06.012","journal-title":"Oral Oncol"},{"key":"2362_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan8355","author":"B Serrels","year":"2017","unstructured":"Serrels B, McGivern N, Canel M, Byron A, Johnson SC, McSorley HJ, Quinn N, Taggart D, Von Kreigsheim A, Anderton SM, Serrels A, Frame MC (2017) IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks. Sci Signal. \n                    https:\/\/doi.org\/10.1126\/scisignal.aan8355","journal-title":"Sci Signal"},{"key":"2362_CR48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1647","volume":"5","author":"GW McLean","year":"2005","unstructured":"McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC (2005) The role of focal-adhesion kinase in cancer\u2014a new therapeutic opportunity. Nat Rev Cancer 5:505. \n                    https:\/\/doi.org\/10.1038\/nrc1647","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2362_CR49","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/1078-0432.ccr-08-1463","volume":"15","author":"JP Klussmann","year":"2009","unstructured":"Klussmann JP, Mooren JJ, Lehnen M, Claessen SMH, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I, Preuss SF, Straetmans JMJAA, Manni JJ, Hopman AHN, Speel E-JM (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15(5):1779\u20131786. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-1463","journal-title":"Clin Cancer Res"},{"issue":"29","key":"2362_CR50","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1200\/JCO.2015.62.1086","volume":"33","author":"DN Hayes","year":"2015","unstructured":"Hayes DN, Van Waes C, Seiwert TY (2015) Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors. J Clin Oncol 33(29):3227\u20133234. \n                    https:\/\/doi.org\/10.1200\/JCO.2015.62.1086","journal-title":"J Clin Oncol"},{"issue":"7536","key":"2362_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"MSea Lawrence","year":"2015","unstructured":"Lawrence MSea (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576\u2013582. \n                    https:\/\/doi.org\/10.1038\/nature14129","journal-title":"Nature"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-019-02362-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:10:29Z","timestamp":1592953829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-019-02362-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1007\/s00262-019-02362-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Research Ethics Board of the Hospital District of Helsinki and Uusimaa, Finland approved the study design (Dnr: 51\/13\/03\/02\/2013) and an institutional study permission was granted. All applicable ethical guidelines and legislation were followed, and the study design complies with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and ethical standards"}},{"value":"Informed consent was obtained from all participants included in the study. Informed consent included the permission to take blood samples. Additionally, it included permission to use the blood samples and tumor samples of the participants for further analyses and research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}